Tascit is an extended release wax matrix tablet containing potassium
citrate as its active ingredient.
Tascit is used for the management of:
Tascit has been produced using AccuRelease Technology that ensures a consistent release of potassium citrate in the patient’s body. This not only ensures a more constant level of urinary citrate, but also mitigates the gastrointestinal side effects usually associated with immediate release preparations.
Tascit comes in 2 dosage forms – the 10 mEq tablet and the 15 mEq tablet
Know more about this product, the technology behind it and more of the benefits you will get by using it.
Video Coming Soon.